11 results
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
.
Occurrence of serious treatment-related side effects could impede subject recruitment and clinical trial enrollment or the ability of enrolled patients … recruitment and retention efforts are unsuccessful in the future, it may be difficult for us to implement business strategy, which could harm our business
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
recruitment and clinical trial enrollment or the ability of enrolled patients to complete the trial, delay the clinical trial, and prevent receipt … and private research institutions and other organizations. If our recruitment and retention efforts are unsuccessful in the future, it may be difficult
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
-related side effects could impede subject recruitment and clinical trial enrollment or the ability of enrolled patients to complete the trial, delay … for personnel from other companies, universities, public and private research institutions and other organizations. If our recruitment and retention efforts
DRS
BHVN
Biohaven Ltd.
11 Oct 22
Draft registration statement
12:00am
further development of the compound in the tested indication.
Occurrence of serious treatment-related side effects could impede subject recruitment … , universities, public and private research institutions and other organizations. If our recruitment and retention efforts are unsuccessful in the future, it may
10-12B/A
EX-99.1
zdg0n7mb4kjh1882sf
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
quwol9jyth
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
i2b5k g7zj
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
8xiqi
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
fr69qxvu
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
p20fhfy0qjpfs50
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next